Skip to main content
Sign In

We are a nationally recognized department of Ophthalmology.

Othamology Banner Image
 

Faculty Publications

Jon M Braverman, MD


The following data are linked to original publications.

 

  1. Diabetic Retinopathy Clinical Research Network (Site Investigator). Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (In-Press).
  2. Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, Ferris FL, Glassman AR, Ip MS, Miller KM, for the Diabetic Retinopathy Clinical Research Network (Site Investigator). Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2010; 117: 946-953.
  3. Bressler NM, Edwards AR, Beck RW, Flaxel CJ, Glassman AR, Ip MS, Kollman C, Kuppermann BD, Stone TW; Diabetic Retinopathy Clinical Research Network (Site Investigator). Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol. 2009 Dec; 127(12): 1566-71.
  4. Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, et al. and the SCORE Study Investigator Group (Site Investigator).  SCORE Study Report 3: Study Design and Baseline Characteristics.  Ophthalmology 2009; 116: 1770-1777.
  5. Diabetic Retinopathy Clinical Research Network (DRCR.net) (Site Investigator), Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, Hartnett E, Ip MS, Kim JE, Kollman C. Three-year follow up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009 Mar; 127(3): 245-51.
  6. The SCORE Study Research Group (Site Investigator).  A Randomized Trial Comparing the Efficay and Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion. Archives of Ophthalmology 2009; 127(9): 1101-1114.
  7. The SCORE Study Research Group (Site Investigator).  A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion. Archives of Ophthalmology 2009; 127(9): 1115-1128.
  8. Diabetic Retinopathy Clinical Research Network (Site Investigator). A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008 Sep; 115(9): 1447-9.e1-10.
  9. Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H; Diabetic Retinopathy Clinical Research Network (Site Investigator). A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features. Retina 2008 Jul-Aug; 28(7): 919-30.
  10. Bhavsar AR, Ip MS, Glassman AR; DRCRnet and the SCORE Study Groups (Site Investigator). The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol. 2007 Sep; 144(3): 454-6